Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study
- 24 July 2025
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 48 (10) , 1766-1773
Abstract
OBJECTIVE: Nocturnal hypoglycemia is challenging for individuals with type 1 diabetes, particularly those who are physically active or using multiple daily injections (MDIs). We hypothesized that adding bedtime decision support to usual care with continuous glucose monitoring (CGM)–augmented MDI therapy could reduce nocturnal hypoglycemia. RESEARCH DESIGN AND METHODS: We developed the DailyDose Smart Snack (DDSS) app, which features CGM and physical activity logging and delivers personalized bedtime snack recommendations to help prevent nocturnal hypoglycemia. Recommendations are based on the probability and timing of low-glucose events forecasted by an evidential neural network. We conducted a randomized crossover trial comparing DDSS with CGM-augmented MDI for 4 weeks each under free-living conditions to evaluate the feasibility and effect of DDSS in reducing nocturnal hypoglycemia. RESULTS: Twenty participants completed the study (mean ± SD age 39 ± 15 years; 10 women; HbA1c 7.1% ± 1.0% [54 ± 11 mmol/mol]). There was no difference between arms in the proportion of nights with low-glucose events <70 mg/dL lasting ≥10 min (control 26.0% ± 14.1% vs. DDSS 23.6% ± 15.6%; odds ratio [OR] 0.83; P = 0.207) or in overnight CGM metrics. A post hoc analysis showed that the proportion of nights with low-glucose events <54 mg/dL lasting ≥10 min was significantly reduced in the DDSS arm by 3.5% (11.9% ± 12.9% vs. 8.3% ± 8.8%; OR 0.64; P = 0.040). CONCLUSIONS: DDSS did not significantly reduce the proportion of nights with low-glucose events <70 mg/dL lasting ≥10 min but reduced nocturnal low glucose <54 mg/dL without compromising other glycemic metrics.Keywords
All Related Versions
Funding Information
- Division of Diabetes, Endocrinology, and Metabolic Diseases (NIH/NIDDK 5R21DK128582)
This publication has 37 references indexed in Scilit:
- Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin InjectionsDiabetes Technology & Therapeutics, 2022
- A hypoglycemia early alarm method for patients with type 1 diabetes based on multi-dimensional sequential pattern miningHeliyon, 2022
- Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily InjectionsDiabetes Technology & Therapeutics, 2021
- Predicting and Preventing Nocturnal Hypoglycemia in Type 1 Diabetes Using Big Data Analytics and Decision Theoretic AnalysisDiabetes Technology & Therapeutics, 2020
- An artificial intelligence decision support system for the management of type 1 diabetesNature Metabolism, 2020
- Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover studyThe Lancet Diabetes & Endocrinology, 2017
- A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables.Psychological Methods, 2006
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- Multiplicity in randomised trials I: endpoints and treatmentsThe Lancet, 2005
- Epidemiology of severe hypoglycemia in the diabetes control and complications trialThe American Journal of Medicine, 1991